Comparison between Anand Rathi Share IPO and Anthem Biosciences IPO.
Anand Rathi Share IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Anthem Biosciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anand Rathi Share IPO is up to ₹745.64 Cr whereas the issue size of the Anthem Biosciences IPO is up to ₹3,395.00 Cr. The final issue price of Anand Rathi Share IPO is ₹414.00 per share and of Anthem Biosciences IPO is ₹570.00 per share.
| Anand Rathi Share IPO | Anthem Biosciences IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹2 per share |
| Issue Price (Lower) | ₹393.00 per share | ₹540.00 per share |
| Issue Price (Upper) | ₹414.00 per share | ₹570.00 per share |
| Issue Price (Final) | ₹414.00 per share | ₹570.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹25.00 per share | ₹50.00 per share |
| Market Lot Size | 36 shares | 26 shares |
| Fresh Issue Size | 1,80,10,692 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹745.64 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 5,95,75,319 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹3,395.00 Cr |
| Issue Size Total | 1,80,10,692 shares | 5,95,75,319 shares |
| Issue Size Total (Amount) | up to ₹745.64 Cr | up to ₹3,395.00 Cr |
Anand Rathi Share IPO opens on Sep 23, 2025, while Anthem Biosciences IPO opens on Jul 14, 2025. The closing date of Anand Rathi Share IPO and Anthem Biosciences IPO is Sep 25, 2025, and Jul 16, 2025, respectively.
| Anand Rathi Share IPO | Anthem Biosciences IPO | |
|---|---|---|
| Anchor Bid Date | Sep 22, 2025 | Jul 11, 2025 |
| Issue Open | Sep 23, 2025 | Jul 14, 2025 |
| Issue Close | Sep 25, 2025 | Jul 16, 2025 |
| Basis Of Allotment (Tentative) | Sep 26, 2025 | Jul 17, 2025 |
| Initiation of Refunds (Tentative) | Sep 29, 2025 | Jul 18, 2025 |
| Credit of Share (Tentative) | Sep 29, 2025 | Jul 18, 2025 |
| Listing date (Tentative) | Sep 30, 2025 | Jul 21, 2025 |
| Anchor Lockin End date 1 | Oct 25, 2025 | Aug 15, 2025 |
| Anchor Lockin End date 2 | Dec 24, 2025 | Oct 14, 2025 |
Anand Rathi Share IPO P/E ratio is 17.87, as compared to Anthem Biosciences IPO P/E ratio of 70.62.
| Anand Rathi Share IPO | Anthem Biosciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Anand Rathi Share & Stock Brokers Ltd.'s revenue increased by 24% and profit after tax (PAT) rose by 34% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Anthem Biosciences Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.06 | 76.87 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.9 | 74.68 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.87 | 70.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2596.18 Cr. | ₹31867.39 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.12% | 20.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.32% | 26.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.80 | 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹23.17 | ₹8.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.12% | 20.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anand Rathi Share IPO Retail Individual Investors (RII) are offered 62,13,769 shares while in Anthem Biosciences IPO retail investors are offered 62,13,769 shares. Qualified Institutional Buyers (QIB) are offered 35,50,724 shares in Anand Rathi Share IPO and 1,18,83,333 shares in Anthem Biosciences IPO.
| Anand Rathi Share IPO | Anthem Biosciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 53,26,086 shares | 1,78,24,999 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 35,50,724 shares | 1,18,83,333 shares |
| NII | 26,63,044 shares | 89,12,500 shares |
| RII | 62,13,769 shares | 2,07,95,834 shares |
| Employee | 2,57,069 shares | 1,58,653 shares |
| Others | ||
| Total | 1,80,10,692 shares | 5,95,75,319 shares |
Anand Rathi Share IPO subscribed 21.83x in total, whereas Anthem Biosciences IPO subscribed 67.42x.
| Anand Rathi Share IPO | Anthem Biosciences IPO | |
|---|---|---|
| QIB (times) | 46.25x | 192.80x |
| NII (times) | 30.16x | 44.70x |
| Big NII (times) | 32.01x | 51.66x |
| Small NII (times) | 26.45x | 30.80x |
| RII (times) | 5.11x | 5.98x |
| Employee (times) | 2.70x | 6.99x |
| Other (times) | ||
| Total (times) | 21.83x | 67.42x |
